UFP Technologies Inc. Reports Strong Q2 Results for 2024
Overview
UFP Technologies Inc. (NASDAQ: UFPT), a leading manufacturer specializing in advanced solutions for the medical device sector, among other markets, has released its financial results for the second quarter of 2024. The company continues to demonstrate robust performance with significant growth in sales and net income compared to the prior year.
1. Financial Highlights
UFP Technologies' net sales for the three-month period ending June 30, 2024, increased approximately 10.1%, reaching $110.2 million, up from $100.0 million during the same period in 2023. This positive momentum continued into the first half of the year, with net sales of $215.2 million for the six-month period, reflecting an 8.8% increase from $197.8 million in the first half of 2023.
Income and Margins
The company reported a gross margin of 30.0% for Q2 2024, a slight increase from 29.6% in Q2 2023. However, for the six-month period, the gross margin dipped marginally to 29.3% from 29.5% year-over-year. This indicates a consistent focus on maintaining profitability despite rising costs in some operational areas.
UFP Technologies saw a net income of $14.3 million for Q2 2024, up from $12.4 million in Q2 2023. The net income for the first half of 2024 also increased to $26.2 million, compared to $23.4 million in the same period last year. This performance underscores the company's strength in both revenue generation and cost management.
| Aug 2023 | Aug 2024 | |
|---|---|---|
Net Income | 49.62M | 49.54M |
Profit | 49.62M | 49.54M |
Net Income Continuing | 49.62M | 49.54M |
Income Tax Expense | 13.25M | 9.19M |
Pretax Income | 62.87M | 58.74M |
Non-operating Income | -3.84M | -2.91M |
Operating Income | 66.72M | 61.65M |
Revenue | 385.9M | 417.4M |
Costs and Expenses | 319.2M | 355.8M |
Cost of Revenue | 278.8M | 300.4M |
Operating Expenses | 40.42M | 55.33M |
Selling, General & Administrative | 49.01M | 53.39M |
Other Operating Expenses | -8.58M | 1.94M |
2. Operating Expenses
Selling, general, and administrative expenses (SG&A) increased approximately 13.0% to $13.9 million during Q2 2024, up from $12.3 million in Q2 2023. For the first half of the year, SG&A rose by about 9.9%, totaling $27.8 million compared to $25.3 million in the same period of 2023. The rise in SG&A expenses reflects the company's ongoing investment in growth and operational efficiency.
3. Liquidity and Capital Resources
UFP Technologies generated approximately $22.4 million in cash from operations during the first half of 2024. As of June 30, 2024, the company had $35.2 million in borrowings outstanding under its credit agreement, which allows for borrowings of up to $150 million and is scheduled to mature on June 27, 2029. This solid liquidity position is a testament to the company's effective cash management strategies.
Balance Sheet Overview
As of June 30, 2024, UFP Technologies reported total assets of $416.1 million, an increase from $392.1 million a year earlier. Total liabilities were recorded at $112.2 million, down from $137.7 million in 2023, which further strengthens the company’s financial health.
| Aug 2023 | Aug 2024 | |
|---|---|---|
Total Assets | 392.1M | 416.1M |
Total Current Assets | 137.0M | 162.1M |
Cash and Equivalents | 5.29M | 16.72M |
Net Inventories | 63.04M | 77.97M |
Accounts Receivable | 64.09M | 60.98M |
Non-trade Receivables | 0 | 2.17M |
Prepaid Expenses | 4.64M | 4.29M |
Total Non-current Assets | 255.1M | 254.0M |
Intangible Assets | 179.4M | 177.9M |
Non-current Deferred Tax Assets | 1.92M | 72K |
Net PP&E | 59.83M | 63.73M |
Lease Assets | 13.93M | 12.22M |
Total Liabilities and Equity | 397.9M | 422.3M |
Total Liabilities | 137.7M | 112.2M |
Total Current Liabilities | 52.99M | 51.78M |
Accounts Payable and Accrued Liabilities | 42.11M | 43.95M |
Current Debt | 6.61M | 3.28M |
Current Deferred Revenue | 4.26M | 4.55M |
Total Non-current Liabilities | 84.71M | 60.43M |
Long-term Debt | 53M | 35.2M |
Non-current Deferred Compensation | 5.00M | 5.81M |
Non-current Deferred Tax Liabilities | 458K | 182K |
Other Non-current Liabilities | 26.25M | 19.23M |
Total Equity and Non-controlling Interests | 260.2M | 310.1M |
Total Equity | 260.2M | 310.1M |
4. Segment Performance
UFP Technologies operates primarily in two segments: Medical and Industrial. The Medical segment accounted for approximately 83.1% of the company's net sales in the first half of 2024, highlighting the company's strong position in the healthcare market. The Industrial segment contributed 16.9% of net sales, indicating a diversified revenue stream.
5. Geographic Reach
The company's revenue is derived from a broad geographic base, with significant contributions from customers in the United States, Europe, and Asia. This global presence allows UFP Technologies to capitalize on various market opportunities and mitigate risks associated with regional economic fluctuations.
6. Strategic Acquisitions
In a strategic move to enhance its market position, UFP Technologies acquired Marble Medical, a medical device company, during the second quarter of 2024. This acquisition aligns with the company's goal to expand its product offerings and market reach. Management indicated that they are open to considering additional acquisitions that complement their business model.
7. Conclusion
UFP Technologies Inc. has demonstrated strong performance in Q2 2024, with significant growth in net sales and net income. The company's strategic investments, combined with its robust operational performance, position it well for continued success in the competitive landscape of custom manufacturing. As UFP Technologies continues to explore growth opportunities, stakeholders can be optimistic about its future prospects.
With a strong financial foundation and an unwavering commitment to innovation, UFP Technologies is poised to capitalize on emerging trends in the medical device sector and beyond.
